Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announces that it has entered into a binding arrangement agreement with CB Biotechnology, LLC (the “Purchaser”), an affiliate of Future Pak, LLC (“Future Pak”), a privately held contract manufacturer, packager and distributor of pharmaceutical and nutraceutical products, whereby the Purchaser will acquire all the issued and outstanding common shares of the Company for US$3.01 per share in cash plus one contingent value right (“CVR”) per share for additional aggregate cash payments of up to US$1.19 per CVR if certain milestones are achieved (the “Transaction”). The total Transaction consideration, assuming full payment of the CVRs, is US$254 million.
Read the full article: Theratechnologies Enters into Definitive Agreement to Be Acquired by CB Biotechnology, an Affiliate of Future Pak //
Source: https://www.globenewswire.com/news-release/2025/07/03/3109628/0/en/Theratechnologies-enters-into-Definitive-Agreement-to-be-Acquired-by-CB-Biotechnology-an-Affiliate-of-Future-Pak.html